BRAIN Biotech AG
FSX:BNN.DE
2.64 (EUR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 55.335 | 49.509 | 38.389 | 38.225 | 38.56 | 27.051 | 24.105 | 22.79 | 21.132 | 12.988 | 10.135 | 7.476 |
| Cost of Revenue
| 25.213 | 22.062 | 16.819 | 17.025 | 17.446 | 13.66 | 11.359 | 11.421 | 10.985 | 4.975 | 4.317 | 4.02 |
| Gross Profit
| 30.122 | 27.447 | 21.57 | 21.2 | 21.114 | 13.391 | 12.746 | 11.369 | 10.148 | 8.013 | 5.817 | 3.456 |
| Gross Profit Ratio
| 0.544 | 0.554 | 0.562 | 0.555 | 0.548 | 0.495 | 0.529 | 0.499 | 0.48 | 0.617 | 0.574 | 0.462 |
| Reseach & Development Expenses
| 4.979 | 4.87 | 5.384 | 5.789 | 7.82 | 7.577 | 8.068 | 5.848 | 6.184 | 5.799 | 6.084 | 4.84 |
| General & Administrative Expenses
| 2.573 | 2.104 | 1.347 | 1.749 | 1.333 | 2.117 | 1.596 | 2.96 | 1.01 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 2.807 | 2.193 | 1.371 | 1.578 | 2.329 | 1.928 | 1.635 | 1.529 | 1.411 | 0 | 0 | 0 |
| SG&A
| 5.38 | 4.297 | 2.718 | 3.327 | 3.662 | 4.045 | 3.231 | 4.489 | 2.421 | 8.995 | 6.466 | 5.549 |
| Other Expenses
| 0.118 | 30.038 | 26.684 | 25.859 | 23.103 | 19.387 | 0.216 | 0.226 | 0.488 | 0 | 0 | 0 |
| Operating Expenses
| 35.704 | 34.335 | 29.402 | 29.186 | 26.765 | 23.432 | 22.125 | 25.416 | 15.326 | 12.978 | 10.228 | 9.179 |
| Operating Income
| -5.48 | -6.888 | -7.832 | -7.986 | -5.651 | -10.041 | -9.374 | -13.812 | -4.573 | -4.944 | -4.389 | -5.67 |
| Operating Income Ratio
| -0.099 | -0.139 | -0.204 | -0.209 | -0.147 | -0.371 | -0.389 | -0.606 | -0.216 | -0.381 | -0.433 | -0.758 |
| Total Other Income Expenses Net
| -2.009 | 0.723 | 3.556 | -1.958 | -4.835 | 1.546 | -0.019 | -0.38 | -0.324 | -0.717 | -0.253 | -0.182 |
| Income Before Tax
| -7.489 | -6.165 | -4.276 | -9.944 | -10.486 | -8.495 | -9.398 | -14.427 | -5.502 | -5.661 | -4.641 | -5.852 |
| Income Before Tax Ratio
| -0.135 | -0.125 | -0.111 | -0.26 | -0.272 | -0.314 | -0.39 | -0.633 | -0.26 | -0.436 | -0.458 | -0.783 |
| Income Tax Expense
| 0.625 | 0.176 | 0.403 | -0.927 | 0.009 | -0.219 | 0.273 | 0.511 | 0.452 | 0.26 | 0.124 | 0.013 |
| Net Income
| -8.279 | -6.341 | -4.679 | -9.017 | -10.495 | -8.276 | -9.607 | -14.69 | -5.715 | -5.044 | -4.095 | -5.537 |
| Net Income Ratio
| -0.15 | -0.128 | -0.122 | -0.236 | -0.272 | -0.306 | -0.399 | -0.645 | -0.27 | -0.388 | -0.404 | -0.741 |
| EPS
| -0.38 | -0.29 | -0.23 | -0.48 | -0.58 | -0.46 | -0.58 | -0.97 | -0.45 | -0.4 | -0.35 | -0.48 |
| EPS Diluted
| -0.38 | -0.29 | -0.23 | -0.48 | -0.58 | -0.46 | -0.58 | -0.97 | -0.45 | -0.4 | -0.35 | -0.48 |
| EBITDA
| -2.417 | -4.388 | -1.63 | -5.195 | -5.527 | -5.046 | -7.589 | -12.843 | -3.611 | -3.939 | -3.718 | -5.009 |
| EBITDA Ratio
| -0.044 | -0.089 | -0.042 | -0.136 | -0.143 | -0.187 | -0.315 | -0.564 | -0.171 | -0.303 | -0.367 | -0.67 |